Regional Enterprise Value Over E B I T D A from 2010 to 2024
| RHE Stock | USD 1.74 0.04 2.35% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 39.60121089 | Current Value 41.58 | Quarterly Volatility 14.5 K |
Check Regional Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regional Health's main balance sheet or income statement drivers, such as Interest Expense of 4.5 M, Total Revenue of 16.3 M or Gross Profit of 4 M, as well as many indicators such as Price To Sales Ratio of 0.18, Dividend Yield of 1.6 or PTB Ratio of 21.63. Regional financial statements analysis is a perfect complement when working with Regional Health Valuation or Volatility modules.
Regional | Enterprise Value Over E B I T D A |
Latest Regional Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Regional Health Properties over the last few years. It is Regional Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regional Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Regional Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (4,053) | |
| Geometric Mean | 50.38 | |
| Coefficient Of Variation | (358.93) | |
| Mean Deviation | 7,076 | |
| Median | 17.77 | |
| Standard Deviation | 14,548 | |
| Sample Variance | 211.6M | |
| Range | 56.6K | |
| R-Value | (0.05) | |
| Mean Square Error | 227.3M | |
| R-Squared | 0 | |
| Significance | 0.85 | |
| Slope | (168.46) | |
| Total Sum of Squares | 3B |
Regional Enterprise Value Over E B I T D A History
About Regional Health Financial Statements
Regional Health stakeholders use historical fundamental indicators, such as Regional Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Regional Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Regional Health's assets and liabilities are reflected in the revenues and expenses on Regional Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Regional Health Properties. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 39.60 | 41.58 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Regional Health Prop is a strong investment it is important to analyze Regional Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Regional Health's future performance. For an informed investment choice regarding Regional Stock, refer to the following important reports:Check out the analysis of Regional Health Correlation against competitors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regional Health. If investors know Regional will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regional Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.55) | Revenue Per Share 8.558 | Quarterly Revenue Growth (0.06) | Return On Assets (0) | Return On Equity (5.34) |
The market value of Regional Health Prop is measured differently than its book value, which is the value of Regional that is recorded on the company's balance sheet. Investors also form their own opinion of Regional Health's value that differs from its market value or its book value, called intrinsic value, which is Regional Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regional Health's market value can be influenced by many factors that don't directly affect Regional Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regional Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regional Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regional Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.